These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27852111)

  • 1. RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345.
    Gege C
    Expert Opin Ther Pat; 2017 Jan; 27(1):1-8. PubMed ID: 27852111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742.
    Gege C
    Expert Opin Ther Pat; 2016 Jun; 26(6):737-44. PubMed ID: 26895086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid-related orphan receptor γ t modulators: comparison of Glenmark's me-too patent application (WO2015008234) with the originator application from Merck Sharp and Dohme (WO2012106995).
    Gege C
    Expert Opin Ther Pat; 2015; 25(10):1215-21. PubMed ID: 26156084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses.
    Pandya VB; Kumar S; Sachchidanand ; Sharma R; Desai RC
    J Med Chem; 2018 Dec; 61(24):10976-10995. PubMed ID: 30010338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present).
    Sun N; Guo H; Wang Y
    Expert Opin Ther Pat; 2019 Sep; 29(9):663-674. PubMed ID: 31403347
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation.
    Ding Q; Zhao M; Yu B; Bai C; Huang Z
    PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RORγ antagonists and inverse agonists: a patent review.
    Bronner SM; Zbieg JR; Crawford JJ
    Expert Opin Ther Pat; 2017 Jan; 27(1):101-112. PubMed ID: 27629281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of N-(2-benzyl-4-oxochroman-7-yl)-2-(5-(ethylsulfonyl) pyridin-2-yl) acetamide (b12) as a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist.
    Chen L; Su M; Jin Q; Wang CG; Assani I; Wang MX; Zhao SF; Lv SM; Wang JW; Sun B; Li Y; Liao ZX
    Bioorg Chem; 2022 Feb; 119():105483. PubMed ID: 34906860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.
    Imura C; Ueyama A; Sasaki Y; Shimizu M; Furue Y; Tai N; Tsujii K; Katayama K; Okuno T; Shichijo M; Yasui K; Yamamoto M
    J Dermatol Sci; 2019 Mar; 93(3):176-185. PubMed ID: 30905492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting RORγt/Th17 axis for autoimmune disorders.
    Isono F; Fujita-Sato S; Ito S
    Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds.
    Ding Q; Zhao M; Bai C; Yu B; Huang Z
    BMC Immunol; 2015 May; 16():32. PubMed ID: 26021566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitor, S18-000003.
    Sasaki Y; Odan M; Yamamoto S; Kida S; Ueyama A; Shimizu M; Haruna T; Watanabe A; Okuno T
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3549-3553. PubMed ID: 30301676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Th17 Cells with Small Molecules and Small Interference RNA.
    Lin H; Song P; Zhao Y; Xue LJ; Liu Y; Chu CQ
    Mediators Inflamm; 2015; 2015():290657. PubMed ID: 26792955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
    Gege C; Schlüter T; Hoffmann T
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5265-7. PubMed ID: 25305688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RORs in autoimmune disease.
    Chang MR; Rosen H; Griffin PR
    Curr Top Microbiol Immunol; 2014; 378():171-82. PubMed ID: 24728598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
    Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases - where are we presently?
    Gege C
    Expert Opin Drug Discov; 2021 Dec; 16(12):1517-1535. PubMed ID: 34192992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.